Dr. Lisa J. Simmons, MD

Dr. Simmons practices at Hematology-Oncology Associates of Fredericksburg, Inc. in Fredericksburg, Virginia.

Dr. Simmons' NPI, 1790773737, was assigned on October 13, 2005. Dr. Simmons graduated from University of Missouri, Columbia School of Medicine in 1999. Dr. Simmons holds Iowa license 33840.

Dr. Simmons' primary practice is Hematology-Oncology Associates of Fredericksburg, Inc., at 4501 Empire Ct, Fredericksburg, VA 22408 in Spotsylvania County. The practice phone is (540) 371-0079.

Dr. Simmons' primary practice is Hematology-Oncology Associates of Fredericksburg, Inc. in Fredericksburg, Virginia. Dr. Simmons is also affiliated with Mary Washington Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Simmons to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Simmons practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Simmons' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Simmons is licensed in Iowa.

CMS data shows 1,350 Medicare services from Dr. Simmons across 21 procedure codes in 2024, for 293 Medicare patients. Medicare paid $28,473 for them.

CMS counts 293 Medicare patients who saw Dr. Simmons in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Simmons' median patient age at 66, with 61% women.

In 2024, Dr. Simmons wrote 99 Medicare Part D claims for 48 patients. 77% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $10,456 in total drug cost. In 2023, CMS named 79 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Simmons for performance year 2024, reported as part of a group. Dr. Simmons accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Simmons as offering telehealth.

CMS Open Payments shows 562 general payments to Dr. Simmons from 80 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 76% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,053.

Dr. Simmons graduated from University of Missouri, Columbia School of Medicine in 1999.